- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Noram Ventures Inc. (TSXV:NRM) (OTCBB:NRVTF:US) (“Noram” or the “Company”) is pleased to announce the increase in the previously announced private placement from $1,050,000 to a gross total of $1,470,000.
Noram Ventures Inc. (TSXV:NRM) (OTCBB:NRVTF:US) (“Noram” or the “Company”) is pleased to announce the increase in the previously announced private placement from $1,050,000 to a gross total of $1,470,000.
Further to the news release dated August 29, 2018 and due to an overwhelming response, Noram will be increasing the private placement from gross proceeds of $1,050,000 to gross proceeds of $1,470,000. The placement is a unit offering of up to 14,000,000 units at a price of $0.105 per unit. Each unit will be comprised of one common share and one transferable share purchase warrant exercisable at a price of $0.14 for two years from the date of TSX Venture Exchange approval (the “Approval Date”).
Additionally, the Company will be offering a Finder’s Fee of 8% cash and 8% warrants where applicable. Finder’s warrants will have the same terms as the aforementioned warrants. All shares will be subject to a four month and a day hold from the Approval Date. This transaction remains subject to TSX Venture Exchange approval.
For further information, please visit www.noramventures.com
ON BEHALF OF THE BOARD OF DIRECTORS
s/ “Mark Ireton”
President & Director
Direct: (604) 761-9994
mark@noramventures.com
This news release contains projections and forward-looking information that involve various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. The following are important factors that could cause the Company’s actual results to differ materially from those expressed or implied by such forward looking statements; the uncertainty of future profitability; and the uncertainty of access to additional capital. These risks and uncertainties could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Actual results and future events could differ materially from anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and expressed qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking information should circumstance or management’s estimates or opinions change. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Source: cloud.stockwatch.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.